Pfizer Spin Off To Study NF

Posted on: September 27, 2017 by: webmaster

Pfizer spins out SpringWorks Therapeutics to focus on diseases like Neurofibromatosis. Read more at “Pfizer Creates New Smaller Company to Focus on Rare Diseases“.

Donate Now

Your donation helps ensure that the most promising projects are thoroughly explored and funded. View our donation page for all options or donate now using the Donate link below. The NFCA is a nonprofit organization under IRS Code Section 501 (c)(3), Federal Tax ID 25-1763156.

SO THAT WE MAY PROPERLY CREDIT/RECORD YOUR DONATION, PLEASE SELECT AN OPTION UNDER "USE THIS DONATION FOR". ON THE FOLLOWING PAGE, UNDER "WRITE A NOTE", LET US KNOW THE INDIVIDUAL BEING HONORED/MEMORIALIZED, THE SPECIFIC EVENT INFORMATION, AND/OR GENERAL ACKNOWLEDGEMENT INFORMATION.